Abstract
Health expenditure is a particularly sensitive political issue for European Union countries. This is due to the continuing increase in expenditure, the considerable state spending devoted to this field and the questions that are raised on the effectiveness of this state spending. However, going beyond these general factors, there are significant disparities between the situations in the various countries. These reveal differences in the quality of the services provided and costs of these services. These differences may help to understand not only certain disparities in the economic attraction of the countries but also the geographical mobility of patients seeking healthcare. To explain the background in which European health systems operate, this report gives a few introductory remarks on the methodological choices, followed by an overall view of the situation regarding healthcare expenditure, indicating the current trends. The next section comments on the quality of the results obtained given the reimbursement rates provided for the public and the health situation as it stands. Finally, the report comments on the regulatory mechanisms that have been adopted to ensure better use of resources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
For dental care, a ceramic crown (for which there is no set tariff) is half the price in Germany than in France where a large part of the cost is borne by complementary health insurance.
- 2.
System of Health Accounts (SHA).
- 3.
Calculated as purchasing power parity (ppp) to take account of differences in the cost of living between countries.
- 4.
In the United Kingdom, the WANLESS report on “Securing our Future Health”, published in 2002, considered that the country was not investing sufficiently in healthcare and proposed a series of recommendations to increase total health expenditure to 10 % of GDP.
- 5.
Unlike the cure approach, which covers all medical treatment used to cure disease and health problems, the care approach covers all that is related to prevention as well as support for and the attention paid to patients.
- 6.
Such as allergies, diabetes and high blood pressure.
- 7.
These three points were covered in detail in the first report by the Haut Conseil pour l’Avenir de l’Assurance Maladie in 2004.
- 8.
These do not release subscribers from the obligation of contributing to finance the public system.
- 9.
In this context this is “allocative efficiency”.
- 10.
On the political front, poor use of resources can also result in a loss of confidence in state action and reduce willingness to pay taxes.
- 11.
In 2010, Estonia and the Czech Republic were ranked 18th and 16th for life expectancy in the set of 21 European countries considered.
- 12.
This concern with regulation is relatively long-established in Germany as Germany was one of the first European countries to implement a global health expenditure control policy. The Advisory Council for the Concerted Action in Health Care was set up for this purpose in 1977, bringing together all those involved in health.
- 13.
Evaluated according to life expectancy.
- 14.
It is known, for example; that housing, education and environment policies have a direct effect on public health.
- 15.
The obstacles encountered in developing and financing the care related to dependency are a good illustration of these difficulties.
- 16.
The private sector, which is present to some extent in all countries, falls naturally into this system.
- 17.
The effectiveness of medical protocols remains however conditioned to a considerable extent by the way in which the information is made available to the medical corps and by the scope for independence that is left in the recommendations.
References
André JM, Del Sol M, Martin P, Turquet P (2011) L’assurance maladie privée en Europe: situation et tendances actuelles. Le Concours Médical 5:408–412
Barilari A (2000) Le consentement à l’impôt. Presses de Sciences, Po
Barro R, Sala I, Martin X (1995) Economic growth. McGraw Hill, London
Commonwealth Fund (2011) Why not the best? Results from the national scorecard on US health system performance, octobre 2011
Dormont B (2009) Les dépenses de santé, une augmentation salutaire? Editions rue d’Ulm, Paris
DREES (2012) Les comptes nationaux de la santé 2011 Collection Etudes et Statistiques.
Duriez M, Lequet-Slama D (1998) Les systèmes de santé en Europe PUF. Coll. Que sais-je?
Grumbach K, Osmond D, Vranizan K, Jaffe D, Bindman AB (1998) Primary care physicians’ experience of financial incentives in managed care systems. New England Journal of Medicine 339(21):1518
Hartmann L (2003) L’accès aux soins de premiers recours en Europe. Revue française des affaires sociales 2-3:121–139
HCAAM (2004) Rapport du Haut Conseil pour l’Avenir de l’Assurance Maladie
Husson M (2004) La santé: un bien supérieur? Chronique internationale de l’IRES 91:134–150
Jourdain-Menninger D, Lignot-Leloup M (2003) Comparaisons internationales sur la prévention sanitaire Rapport IGAS. La Documentation Française, Paris
Le Pen C, Sicard D (2004) Santé: l’heure de choix. Desclée de Brouwer, Bilbao
Le Pen C (2008) « La rentabilité collective des soins de santé ». Les Tribunes de la santé 2008/4(n° 21):23–30
Mintzberg H (1990) Le management: voyage au centre des organisations. Editions d’Organisation, Paris
OCDE (2011) Panorama de la santé 2011 – Les indicateurs de l’OCDE, S 40–41
OMS (2000) Rapport sur la santé dans le monde – Pour un système de santé plus performant
Petignat PA (2009) Les guidelines sont-ils des standards à suivre? Revue médicale suisse 225:2271–2275
Turquet P (2012) Réformes du financement des systèmes d’assurance maladie aux Pays-Bas, en Allemagne et en France: quelles conséquences en matière de couverture sociale et de redistribution ? Revue internationale de Sécurité sociale 65(1):33–56
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
André, JM. (2014). Health Expenditure in the European Economy. In: Hennion, S., Kaufmann, O. (eds) Unionsbürgerschaft und Patientenfreizügigkeit Citoyenneté Européenne et Libre Circulation des Patients EU Citizenship and Free Movement of Patients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41311-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-41311-7_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41310-0
Online ISBN: 978-3-642-41311-7
eBook Packages: Humanities, Social Science (German Language)